Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A&#xa0;phase&#xa0;IV clinical trial

Further Publications

Case-based Diagnostic Algorithms and Multidimensional Clinical Profiles for common Disorders of Gut-Brain Interaction using Rome V criteria

Am J Gastroenterol

Lacy BE, Farmer AD, Tornblom H

doi: 10.14309/ajg.0000000000004131

Further Publications

Neurofeedback as a non-pharmacological strategy for pain and gut-brain axis disorders: clinical relevance in inflammatory bowel disease

Minerva Gastroenterol (Torino)

Spagnolo G, Ferrarese D, DI Vincenzo F, Iaccarino J, Murgiano M, Vecchione M, Puca P, D'Onofrio AM, Natalello G, D'Agostino MA, Gasbarrini A, Camardese G, Chieffo DP, Scaldaferri F

doi: 10.23736/S2724-5985.26.04026-X

Further Publications

Disorders of Gut-Brain Interaction like symptoms in Children with Inflammatory Bowel Disease: A Multicenter Prospective Study from the Pediatric IBD Porto Group of the ESPGHAN

Am J Gastroenterol

Martinelli M, Salomone S, Strisciuglio C, Zellos A, Romano C, Dipasquale V, Bramuzzo M, Lega S, Aloi M, D'Arcangelo G, Rodríguez-Belvís MV, Colucci A, Miele E, Staiano A, Eleftheria R

doi: 10.14309/ajg.0000000000004140

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Peppermint oil and sweets in pediatric irritable bowel syndrome and functional abdominal pain: a randomized trial

Clin Gastroenterol Hepatol

Vermeijden NK, van der Feen C, Groeneweg M, Hummel T, Zagers D, Bertrams-Maartens I, van Wering H, Hurkmans P, Stapelbroek J, Sauvé I, Wessels M, Teklenburg-Roord S, Pruijsen-Nienhuis JM, Theuns-Valks SDM, Plomp TC, Bunkers C, Keszthelyi D, Benninga MA, Vlieger AM

doi: 10.1016/j.cgh.2026.01.014

Gastrointestinal Cancer

Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial

JAMA Oncol

Lyu N, Yi JZ, Wu XT, Zhang YM, Pan T, Mu LW, Chen S, Wang JL, Xu J, Tan GJ, Zhang YN, Gao ZQ, Ou-Yang ZX, Wu WJ, Song YJ, Deng HJ, He M, Jiang YQ, Chen QF, Li JB, Shi M, Chen MS, Zhao M

doi: 10.1001/jamaoncol.2026.2366

Gastrointestinal Cancer

Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial

Lancet Oncol

Sebag-Montefiore D, Adams R, Gollins S, Samuel LM, Glynne-Jones R, Harte R, West N, Quirke P, Sun Myint A, Bach S, Parsons P, Dhadda AS, Brown N, Brown G, Harrison M, Maggs R, Begum R, Chang E, Hackshaw A, Lopes A, ARISTOTLE Trial Management Group and Investigators

doi: 10.1016/S1470-2045(26)00132-4

Hepatology

Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial

J Hepatol

Schattenberg JM, Bedossa P, Guy CD, Taub R, Labriola D, Zhang H, Hennan J, Camacho RC, Chng E, Ren Y, Tai D, Harrison SA

doi: 10.1016/j.jhep.2026.03.021

Gastrointestinal Cancer

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

Eur J Cancer

Weiss L, Stintzing S, Modest DP, Stahler A, von Weikersthal LF, Reinacher-Schick A, Decker T, Probst V, Heinrich K, Schwaner I, Kaiser F, Pihusch R, Fuchs M, Held S, Alig A, Gruenberger B, Prager GW, Tougeron D, Taieb J, Heinemann V

doi: 10.1016/j.ejca.2025.116105

Inflammatory Bowel Disease

Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis

Inflamm Bowel Dis

Rubin DT, Danese S, Nakase H, Ungaro RC, Wolf DC, Alekseeva O, Petersen A, Liu Z, Mehra D, Jain A, Osterman MT, Krakovich A, Riolo JV, DeBoer E, Appio J, Sinh P, Cree BAC, Cohen JA, Irving P

doi: 10.1093/ibd/izaf319

Gastroenterology

Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial

Related content

Case-based Diagnostic Algorithms and Multidimensional Clinical Profiles for common Disorders of Gut-Brain Interaction using Rome V criteria

Neurofeedback as a non-pharmacological strategy for pain and gut-brain axis disorders: clinical relevance in inflammatory bowel disease

Disorders of Gut-Brain Interaction like symptoms in Children with Inflammatory Bowel Disease: A Multicenter Prospective Study from the Pediatric IBD Porto Group of the ESPGHAN

Peppermint oil and sweets in pediatric irritable bowel syndrome and functional abdominal pain: a randomized trial

Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial

Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial

Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial

First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF(V600E)-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis